Skip to main content
SpringerLink
Log in

Antimicrobial activities of some synthesized 1-(3-(2-methylphenyl)-4-Oxo-3H-quinazolin-2-yl-4-(substituted)thiosemicarbazide derivatives

  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract

The substituted thiosemicarbazide moiety was placed at the C-2 position and 2-methylphenyl group at N-3 position of quinazoline ring and obtained compounds were tested for their antitubercular activities and antibacterial activities against selected gram-positive and gram-negative bacteria. The target compounds 1-(3-(2-methylphenyl)-4-oxo-3H-quinazolin-2-yl)-4-(substituted) thiosemicarbazides were obtained by the reaction of 2-hydrazino-3-(2-methylphenyl) quinazolin-4(3H)-one with different dithiocarbamic acid methyl ester derivatives. All synthesized compounds were also screened for their antimicrobial activity against selective gram-positive and gram-negative bacteria by agar dilution method. Among the series, 1-[3-(2-methylphenyl)-4-oxo-3H-quinazolin-2-yl]-4-[4-chlorophenyl]-thiosemicarbazide exhibited the most potent activity against S. typhi, E. coli, and B. subtilis, while 1-[3-(2-methylphenyl)-4-oxo-3H-quinazolin-2-yl]-4-[4-nitrophenyl]-thiosemicarbazide was the most potent against E. coli, B. subtilis, P. aeruginosa, S. typhi, and S. flexneri. These two compounds exhibited the antitubercular activity at the minimum concentration (3 μg/mL) that offered potential for further optimization and development of new antitubercular agents. The obtained results demonstrated promising antimicrobial and antitubercular activities of the synthesized quinazoline compounds which could be used as new scaffolds for improving their antimicrobial activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Houben, E.N., Nguyen, L., and Pieters, J., Curr. Opin. Microbiol., 2001, vol. 9, pp. 76–85.

    Article  Google Scholar 

  2. Venuti, M.C., Principles and Practice, in Burger’s Medicinal Chemistry and Drug Discovery, 5th ed., Wolff, M.E., Ed., New York: John Wiley and Sons, 1995.

  3. World Health Organization. Fact sheet no. 104, Reviewed March, 2014. http://www.who.int/mediacentre/factsheets/fs104/en

  4. Zia-ur-Rehman, M., Choudary, J.A., Ahmad, S., and Siddiqui, H.L., Chem. Pharm. Bull., 2006, vol. 54, pp. 1175–1178.

    Article  CAS  PubMed  Google Scholar 

  5. Pattan, S.R., Reddy, V.V.K., Manvi, F.V., Desai, B.G., and Bhat. A.R., Indian J. Chem., 2006, vol. 45B, pp. 1778–1781.

    CAS  Google Scholar 

  6. Pavan, F.R., da S Maia, P.I., Leite, S.R., Deflon, V.M., Batista, A.A., Sato, D.N., Franzblau, S.G., and Leite, C.Q., Eur. J. Med. Chem., 2010, vol. 45, pp. 1898–1905.

    Article  CAS  PubMed  Google Scholar 

  7. Güzel, O., Karali, N.,and Salman, A., Bioorg. Med. Chem., 2008, vol. 16, pp. 8976–8987.

    Article  PubMed  Google Scholar 

  8. Karali, N., Gursoy, A., Kandemirli, F., Shvets, N., Kaynak, F.B., Ozbey, S., Kovalishyn, V., and Dimoglo, A., Bioorg. Med. Chem., 2007, vol. 15, pp. 5888–5904.

    Article  CAS  PubMed  Google Scholar 

  9. Sriram, D., Yogeeswari, P., Thirumurugan, R., and Pavana, R.K., J. Med. Chem., 2006, vol. 49, pp. 3448–3450.

    Article  CAS  PubMed  Google Scholar 

  10. Sriram, D., Yogeeswari, P., Dhakla, P., Senthilkumar, P., Banerjee, D., and Manjashetty, T.H., Bioorg. Med. Chem. Lett., 2009, vol. 19, pp. 1152–1154.

    Article  CAS  PubMed  Google Scholar 

  11. Saripinar, E., Guzel, Y., Patat, S., Yildirim, I., Akçamur, Y., and Dimoglo, A.S., Arzneimittelforschung, 1996, vol. 46, pp. 824–828.

    CAS  PubMed  Google Scholar 

  12. Milczarska, B., Foks, H., Sokołowska, J., Janowiec, M., Zwolska, Z., and Andrzejczyk, Z., Acta Pol. Pharm., 1999, vol. 56, pp. 121–126.

    CAS  PubMed  Google Scholar 

  13. Turan-Zitouni, G., Ozdemir, A., Kaplancikli, Z.A. Benkli, K., Chevallet, P., and Akalin, G., Eur. J. Med. Chem., 2008, vol. 43, pp. 981–988.

    Article  CAS  PubMed  Google Scholar 

  14. Pandeya, S.N., Smitha, S., Jyoti, M., and Sridhar, S.K., Acta Pharmaceutica, 2005, vol. 55, pp. 27–46.

    CAS  PubMed  Google Scholar 

  15. Meunier, B., Acc. Chem. Res., 2008, vol. 41, pp. 69–77.

    Article  CAS  PubMed  Google Scholar 

  16. Alagarsamy, V., Solomon, V.R., Sheorey, R.V., and Jayakumar R., Chem.Biol Drug. Des., 2009, vol. 73, pp. 471–479.

    Article  CAS  PubMed  Google Scholar 

  17. Alagarsamy, V., Shankar, D., Solomon, V.R., Sheorey, R.V., and Parthiban, P., Acta Pharm., 2009, vol. 59, pp. 75–79.

    Article  CAS  PubMed  Google Scholar 

  18. Alagarsamy, V. Solomon, V.R. Meena, R. Ramaseshu, K.V., Thirumurugan, K., and Murugesan, S., Med. Chem., 2007, vol. 3, pp. 67–73.

    Article  CAS  PubMed  Google Scholar 

  19. Barry, A., Antibiotics in Laboratory Medicine, 5th ed., Baltimore, MD: William and Wilkins, 1991, vol. 1.

    Google Scholar 

  20. Pandeya, S.N., Sriram, D., Nath, G., and De Clercq, E., IL Farmaco, 1999, vol. 54, pp. 624–628.

    Article  CAS  PubMed  Google Scholar 

  21. Sriram, D., Yogeeswari, P., Basha, J.S., Radha, D.R., and Nagaraja, V., Bioorg. Med. Chem., 2005, vol. 13, pp. 5774–5778.

    Article  CAS  PubMed  Google Scholar 

  22. Shanmugavelan, P., Nagarajan, S., Sathishkumar, M., Ponnuswamy, A., Yogeeswari, P., and Sriram, D., Bioorg. Med. Chem. Lett., 2011, vol. 21, pp. 7273–7278.

    Article  CAS  PubMed  Google Scholar 

  23. Kunes, J., Bazant, J., Pour, M., Waisser, K., Slosárek, M., and Janota, J., IL Farmaco, 2000, vol. 55, pp. 725–729.

    Article  CAS  PubMed  Google Scholar 

  24. Alagarsamy, V., Parthiban, P., Sheorey, R.V., and Solomon, V.R., Anti-Infective Agents, 2012, vol. 10, pp. 105–110.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502294, India

    V. Alagarsamy, M. T. Sulthana, P. Parthiban & V. Raja Solomon

  2. Department of Pharmaceutical Chemistry, Dale View College of Pharmacy and Research Centre, Punalal P.O., Thiruvananthapuram, 695575, India

    G. V. Anjana

  3. Faculty of Pharmacy, the University of Sydney, Sydney, NSW, 2006, Australia

    V. Raja Solomon

Authors
  1. V. Alagarsamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. V. Anjana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. T. Sulthana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Parthiban
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Raja Solomon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Alagarsamy.

Additional information

The article is published in the original.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alagarsamy, V., Anjana, G.V., Sulthana, M.T. et al. Antimicrobial activities of some synthesized 1-(3-(2-methylphenyl)-4-Oxo-3H-quinazolin-2-yl-4-(substituted)thiosemicarbazide derivatives. Russ J Bioorg Chem 42, 332–339 (2016). https://doi.org/10.1134/S106816201603002X

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S106816201603002X

Keywords

Search

Navigation